Insider · CIK 0001170363

MAFFUID PAUL W

Reports to the SEC for 2 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001170363

Forms 4 and 5

Insider transactions

44 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2018-04-02	MABVAX THERAPEUTICS HOLDINGS, INC.M Exercise/Conversion	EXEC. VP, R AND D	MExercise/Conversion	+5,015 sh	—	—	101,612
2018-04-02	MABVAX THERAPEUTICS HOLDINGS, INC.F Tax Payment	EXEC. VP, R AND D	FTax Payment	−1,735 sh	—	—	99,877
2018-04-02	MABVAX THERAPEUTICS HOLDINGS, INC.Restricted Stock UnitM Exercise/Conversion	EXEC. VP, R AND D	MExercise/Conversion	−5,015 sh	—	—	0
2018-02-21	MABVAX THERAPEUTICS HOLDINGS, INC.Option to Purchase Common StockA Award	EXEC. VP, R AND D	AAward	+195K sh	—	—	195,000
2018-01-16	MABVAX THERAPEUTICS HOLDINGS, INC.S Sale	EXEC. VP, R AND D	SSale	−38.1K sh	$0.92	−$35K	283,703
2018-01-12	MABVAX THERAPEUTICS HOLDINGS, INC.S Sale	EXEC. VP, R AND D	SSale	−10.2K sh	$0.96	−$9,798.72	321,757
2018-01-11	MABVAX THERAPEUTICS HOLDINGS, INC.S Sale	EXEC. VP, R AND D	SSale	−35.2K sh	$0.98	−$34.5K	331,964
2018-01-10	MABVAX THERAPEUTICS HOLDINGS, INC.S Sale	EXEC. VP, R AND D	SSale	−60.5K sh	$0.96	−$58.1K	367,130
2018-01-08	MABVAX THERAPEUTICS HOLDINGS, INC.M Exercise/Conversion	EXEC. VP, R AND D	MExercise/Conversion	+406K sh	—	—	427,608
2018-01-08	MABVAX THERAPEUTICS HOLDINGS, INC.Restricted Stock UnitM Exercise/Conversion	EXEC. VP, R AND D	MExercise/Conversion	−406K sh	—	—	0
2017-10-02	MABVAX THERAPEUTICS HOLDINGS, INC.Restricted Stock UnitA Award	EXEC. VP, R AND D	AAward	+308K sh	—	—	307,999
2017-09-15	MABVAX THERAPEUTICS HOLDINGS, INC.Restricted Stock UnitA Award	EXEC. VP, R AND D	AAward	+98.4K sh	—	—	98,383
2017-05-19	MABVAX THERAPEUTICS HOLDINGS, INC.P Purchase	EXEC. VP, R AND D	PPurchase	+2,857 sh	$1.75	+$4,999.75	24,083
2017-05-19	MABVAX THERAPEUTICS HOLDINGS, INC.P Purchase	EXEC. VP, R AND D	PPurchase	+3,228 sh	—	—	27,311
2017-05-19	MABVAX THERAPEUTICS HOLDINGS, INC.Class A WarrantS Sale	EXEC. VP, R AND D	SSale	−2,079 sh	—	—	0
2017-05-19	MABVAX THERAPEUTICS HOLDINGS, INC.Class B WarrantS Sale	EXEC. VP, R AND D	SSale	−2,079 sh	—	—	0
2017-04-12	MABVAX THERAPEUTICS HOLDINGS, INC.S Sale	EXEC. VP, R AND D	SSale	−1,369 sh	$2.00	−$2,738.137	21,226
2017-04-11	MABVAX THERAPEUTICS HOLDINGS, INC.S Sale	EXEC. VP, R AND D	SSale	−200 sh	$2.00	−$400	22,595
2017-04-10	MABVAX THERAPEUTICS HOLDINGS, INC.S Sale	EXEC. VP, R AND D	SSale	−400 sh	$2.00	−$800	22,795
2017-04-07	MABVAX THERAPEUTICS HOLDINGS, INC.S Sale	EXEC. VP, R AND D	SSale	−450 sh	$2.00	−$902.25	23,195
2017-04-06	MABVAX THERAPEUTICS HOLDINGS, INC.S Sale	EXEC. VP, R AND D	SSale	−867 sh	$2.15	−$1,861.883	23,645
2017-04-05	MABVAX THERAPEUTICS HOLDINGS, INC.S Sale	EXEC. VP, R AND D	SSale	−1,800 sh	$2.15	−$3,872.34	24,512
2017-04-04	MABVAX THERAPEUTICS HOLDINGS, INC.S Sale	EXEC. VP, R AND D	SSale	−1,000 sh	$2.25	−$2,250	26,312
2017-04-02	MABVAX THERAPEUTICS HOLDINGS, INC.M Exercise/Conversion	EXEC. VP, R AND D	MExercise/Conversion	+15K sh	—	—	27,312
2017-04-02	MABVAX THERAPEUTICS HOLDINGS, INC.Restricted Stock UnitM Exercise/Conversion	EXEC. VP, R AND D	MExercise/Conversion	−15K sh	—	—	15,046
2017-02-06	MABVAX THERAPEUTICS HOLDINGS, INC.Option to Purchase Common StockA Award	EXEC. VP, R AND D	AAward	+100K sh	$2.99	+$299K	100,000
2017-01-01	MABVAX THERAPEUTICS HOLDINGS, INC.Option to Purchase Common StockA Award	EXEC. VP, R AND D	AAward	+20.1K sh	$3.38	+$67.9K	20,100
2016-08-29	MABVAX THERAPEUTICS HOLDINGS, INC.Option to Purchase Common StockA Award	EXEC. VP, R AND D	AAward	+20.1K sh	$5.00	+$101K	20,100
2016-08-17	MABVAX THERAPEUTICS HOLDINGS, INC.P Purchase	EXEC. VP, R AND D	PPurchase	+2,079 sh	—	—	12,267
2016-08-17	MABVAX THERAPEUTICS HOLDINGS, INC.Class A WarrantP Purchase	EXEC. VP, R AND D	PPurchase	+2,079 sh	—	—	2,079
2016-08-17	MABVAX THERAPEUTICS HOLDINGS, INC.Class B WarrantP Purchase	EXEC. VP, R AND D	PPurchase	+2,079 sh	—	—	2,079
2016-04-04	MABVAX THERAPEUTICS HOLDINGS, INC.M Exercise/Conversion	EXEC. VP, R AND D	MExercise/Conversion	+111K sh	—	—	116,334
2016-04-04	MABVAX THERAPEUTICS HOLDINGS, INC.F Tax Payment	EXEC. VP, R AND D	FTax Payment	−40.9K sh	—	—	75,390
2016-04-04	MABVAX THERAPEUTICS HOLDINGS, INC.Restricted Stock UnitM Exercise/Conversion	EXEC. VP, R AND D	MExercise/Conversion	−111K sh	—	—	222,666
2016-02-16	MABVAX THERAPEUTICS HOLDINGS, INC.Option to Purchase Common StockA Award	EXEC. VP, R AND D	AAward	+60K sh	$0.49	+$29.4K	60,000
2015-04-02	MABVAX THERAPEUTICS HOLDINGS, INC.Option to Buy Common StockA Award	EXEC. VP, R AND D	AAward	+334K sh	$2.30	+$768K	334,000
2015-04-02	MABVAX THERAPEUTICS HOLDINGS, INC.Restricted Stock UnitA Award	EXEC. VP, R AND D	AAward	+334K sh	—	—	334,000
2014-12-16	MABVAX THERAPEUTICS HOLDINGS, INC.P Purchase	EXEC. VP, R AND D	PPurchase	+5,000 sh	$2.85	+$14.3K	5,000
2004-01-18	ARENA PHARMACEUTICALS INCEmployee Stock Option (right to buy)A Award	VP, Pharmaceutical Development	AAward	+40K sh	—	—	40,000
2003-12-31	ARENA PHARMACEUTICALS INCJ Other	VP, Pharmaceutical Development	JOther	+88 sh	$5.10	+$448.8	16,194
2003-09-30	ARENA PHARMACEUTICALS INCJ Other	VP, Pharmaceutical Development	JOther	+162 sh	$5.10	+$826.2	16,106
2003-01-20	ARENA PHARMACEUTICALS INCA Award	VP, Pharmaceutical Development	AAward	+15K sh	$15591.00	+$234M	15,591
2003-01-20	ARENA PHARMACEUTICALS INCEmployee Stock Option (right to buy)D Disposition to Issuer	VP, Pharmaceutical Development	DDisposition to Issuer	−15K sh	—	—	—
2002-12-31	ARENA PHARMACEUTICALS INCA Award	VP, Pharmaceutical Development	AAward	−591 sh	—	—	5.1

Recent filings

Accepted (ET)
Apr 34
MAFFUID PAUL W0001415889-18-000539
SEC(opens sec.gov)
Feb 234
MAFFUID PAUL W0001415889-18-000312
SEC(opens sec.gov)
Jan 184
MAFFUID PAUL W0001415889-18-000083
SEC(opens sec.gov)
Jan 164
MAFFUID PAUL W0001415889-18-000062
SEC(opens sec.gov)
Oct 44
MAFFUID PAUL W0001415889-17-001613
SEC(opens sec.gov)
Sep 184
MAFFUID PAUL W0001415889-17-001501
SEC(opens sec.gov)
Aug 24
MAFFUID PAUL W0001415889-17-001295
SEC(opens sec.gov)
Apr 144
MABVAX THERAPEUTICS HOLDINGS, INC.0001415889-17-000641
SEC(opens sec.gov)
Apr 114
MABVAX THERAPEUTICS HOLDINGS, INC.0001415889-17-000636
SEC(opens sec.gov)

Companies

Address

11588 SORRENTO VALLEY ROAD, SUITE 20

SAN DIEGO, CA, 92121